drugset / Trial / NCT01094990

Efficacy of Dexamethasone for Prevent Vomiting in Leukemic Children Who Receive Intrathecal Chemotherapy

NCT01094990 ↗

Phase 4 Completed 32 enrolled CHANCHAI TRAIVAREE
RandomizedCrossoverQuadruple-blindPrevention

Summary

Null hypothesis The proportions of vomiting are not different between dexamethasone and placebo in the patient after sedation with intravenous ketamine and lumbar puncture with intrathecal chemotherapy Alternative hypothesis The proportions of vomiting are different between dexamethasone and placebo in the patient after sedation with intravenous ketamine and lumbar puncture with intrathecal chemotherapy

Timeline

Start
2011-04
Primary completion
2011-09
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.25 mg/kg Intravenous
Subject Dexamethasone Small molecule 8 mg/m2 Intravenous

Indications